Research

David Lubinski co-directs the Study of Mathematically Precocious Youth, a 50-year longitudinal study of more than 5,000 highly talented individuals. Read More

Astronomer David Weintraub, who is an expert on Pluto, reacts to the new images of the distant world and its twin, Charon, coming back from the New Horizons spacecraft. Read More

Over four years, the Vanderbilt-led study will provide 360 Metro Nashville Public School second-graders with one-to-one math tutoring. Read More

The School Administrative Manager process gives principals more time to provide instructional leadership, according to a report co-authored by Peabody College professor Ellen Goldring. Read More

An extensive new survey of federal executives led by Vanderbilt's David E. Lewis has resulted in suggestions on how the civil service system can be improved. Read More

Vanderbilt and Stanford investigators have discovered how a protein that's part of the DNA replication "machinery" helps cells tolerate DNA damage. Read More

Vanderbilt University Medical Center (VUMC), the Human Vaccines Project and the International AIDS Vaccine Initiative (IAVI) announced this week that VUMC has become the project’s first scientific hub. Read More

Research at Vanderbilt University Medical Center aimed at developing potential new treatments for major depressive disorder, general anxiety disorder and post-traumatic stress disorder got a big boost this week from The William K. Warren Foundation of Tulsa, Oklahoma. Read More

Albert Einstein once wrote, “It is the supreme art of the teacher to awaken joy in creative expression and knowledge.” For Emily Hodges, Ph.D., that awakening occurred in a high school science class taught by Trudy Anderson, Ed.D. “She made science exciting,” Hodges said. Read More

Soldiers who served in the glaring desert sunlight of Iraq and Afghanistan returned home with an increased risk of skin cancer, due not only to the desert climate, but also a lack of sun protection, Vanderbilt dermatologist Jennifer Powers, M.D., reports in a study published recently in the Journal of Investigative Dermatology. Read More

Vanderbilt investigators have developed a new algorithm to understand the networks of signaling molecules that control drug action. Read More

Viruses, not bacteria, are the most commonly detected respiratory pathogens in U.S. adults hospitalized with pneumonia, according to a New England Journal of Medicine study released today and conducted by researchers at Centers for Disease Control and Prevention (CDC) and hospitals in Chicago and Nashville, including Vanderbilt University Medical Center. Read More

A new mouse model demonstrates that the Hhex gene – which is linked to blood cancers – is critical for normal blood cell production. Read More

In his effort to develop better prosthetic limbs, Karl Zelik had to start with deciphering more clearly how muscles function in walking. His path not only led to a better way of quantifying human locomotion, but also to the discovery that muscles around the hip and in the foot are more important to walking than previously thought. Read More

A polymer hydrogel material developed by Vanderbilt scientists improved the delivery of stem cells for heart repair. Read More

The AmericasBarometer survey is the only scientifically rigorous comparative survey that covers all of North, Central, and South America, as well as a significant number of countries in the Caribbean. Read More

Vanderbilt researchers have discovered a possible molecular mechanism of schizophrenia that could lead to new treatments for the disorder. Read More

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given. Read More

Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine. Read More

Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus. Read More